pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: COVID-19

Sep 27, 2023

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

Sep 18, 2023

OyaGen, Inc. announces a new publication for its COVID therapeutic in development and publication of related patents

Jul 20, 2023

LinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses

Jun 5, 2023

Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)

Apr 27, 2023

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine USA - English APAC - English

Apr 26, 2023

Tevogen Bio CSO to Discuss Investigational T Cell Therapy at NOLA Conference Focused on Long COVID and COVID-Related Cancer Risk, Alongside Leading Oncology Experts

Apr 20, 2023

Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy

Apr 20, 2023

Cantex and Michigan Medicine Announce Initiation of a Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Clinical Study to Determine the Safety and Efficacy of Azeliragon in the Treatment of Patients Hospitalized for COVID-19

Apr 19, 2023

CORRECTING and REPLACING Direct Biologics Reports Compelling Data as ExoFlo™ Expanded Access Program in Hospitalized COVID-19 Patients with Moderate-to-Severe ARDS Surpasses 100 Subjects

Apr 13, 2023

Peel Therapeutics Reports Excessive NETosis Induction in Long COVID

Mar 14, 2023

Direct Biologics Reports Compelling Results From Phase 2 Trial With ExoFlo™ in Hospitalized Patients With Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19

Mar 7, 2023

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Feb 23, 2023

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

Jan 23, 2023

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

Dec 27, 2022

Clene Nanomedicine Reports Topline Results of Phase 2 COVID-19 Study of CNM-ZnAg

Dec 7, 2022

Tevogen Bio to Study its Investigational COVID-19 T Cell Therapy in Immunocompromised Patients Who are Unable to Benefit From Currently Available Prevention or Treatment Options

Dec 5, 2022

Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate

Nov 28, 2022

Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions

Nov 22, 2022

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Nov 8, 2022

Vaxxas Announces Initiation of Phase I Clinical Study of First Needle-Free COVID-19 Vaccine (HexaPro) Delivered Using High-Density Microarray Patch (HD-MAP)

Nov 1, 2022

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

Oct 27, 2022

Tevogen Bio CEO Ryan Saadi and CSO Neal Flomenberg share White House concerns about emerging COVID-19 variants and impact on immunocompromised patients, and express commitment to accelerate development of company’s investigational COVID-19 therapy

Oct 26, 2022

Codagenix Initiates Dosing in Phase 3 Efficacy Trial of Intranasal COVID-19 Vaccine as Part of WHO-Sponsored Solidarity Trial Vaccines

Oct 25, 2022

Inotrem Announces That Its ESSENTIAL Phase II Study for the Treatment of Critically ill COVID-19 Patients Meets Its Primary and Key Secondary Endpoints

Oct 10, 2022

Therapeutic Solutions International Granted Landmark United States Patent on Ability of QuadraMune Nutraceutical to Repair Injured Brains

Sep 29, 2022

Entos Pharmaceuticals Passes Significant Enrollment Milestone in Phase 2 Clinical Trial of its COVID-19 DNA Vaccine

Sep 28, 2022

SAB Biotherapeutics Unveils New Data at ISIRV OPTIONS XI Conference Validating SAB-176 Proof of Concept in Reducing Viral Load and Improving Symptoms of Influenza and Showing SAB-185 Effective Against Multiple COVID-19 Variants Including Omicron

Sep 12, 2022

Therapeutic Solutions International Develops Post JadiCell Maintenance Therapy for Chronic Obstructive Pulmonary Disease (COPD)

Sep 8, 2022

YishengBio Received Approvals From Philippines and UAE For Phase 2 / 3 Clinical Trials of PIKA Recombinant COVID-19 vaccine

Aug 29, 2022

AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate

Aug 24, 2022

SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Aug 1, 2022

Tevogen Bio Announces Positive Safety Results Upon Completion of Patient Enrollment in Proof-of-Concept Clinical Trial of T cell Therapy for Elderly or High-Risk COVID-19 Patients

Jul 27, 2022

Meissa Vaccines Presented at The White House Summit on the Future of COVID-19 Vaccines

Jul 25, 2022

Ashvattha Therapeutics Announces Publication of Data in Science Translational Medicine from Phase 2a Clinical Trial for OP-101 in Severe COVID-19 Showing Significant Reduction in Inflammatory and Neuroinflammatory Markers and Improved Clinical Outcomes

Jul 18, 2022

Therapeutic Solutions International Granted Emergency IND by FDA for Expanded Patient Access to JadiCell™ Universal Donor Stem Cell for COVID-19 ARDS Outside of Ongoing Phase III Clinical Trial

Jul 13, 2022

Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

Jul 13, 2022

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

Jun 28, 2022

EnGeneIC’s second generation COVID-19 vaccine protects against all variants

Jun 24, 2022

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Jun 7, 2022

Tevogen Bio Initiates Final Dose Level in Proof-of-Concept Clinical Trial of its Investigational T cell Therapy for High-Risk COVID-19 Patients

May 25, 2022

Therapeutic Solutions International Recruits Dr. Donald Banerji to Scientific Advisory Board

May 25, 2022

Codagenix Initiates Phase 1 Evaluation of Intranasal Vaccine CoviLiv™ for Use as COVID-19 Booster

May 12, 2022

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

May 11, 2022

Sound Pharmaceuticals' NIH Grant for a novel oral COVID-19 treatment increases to $4.2M

May 11, 2022

Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is Effective at Preventing COVID-19 after High-Risk Exposure

May 6, 2022

Sen-Jam Pharmaceutical Opens Enrollment for Patients in Their COVID Therapy Phase 2 Clinical Trial in Nepal and Engages With Strategic Investor for Worldwide Distribution

May 5, 2022

Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine

May 4, 2022

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

May 2, 2022

Affinivax to Highlight Preclinical Data from COVID-19 MAPS™ Vaccine Development Program at IMMUNOLOGY2022™

May 2, 2022

Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug

Apr 19, 2022

Endpoint Health Presents New Research at Society of Critical Care Medicine’s 2022 Critical Care Congress, Predicting Outcomes for Common Treatment Strategies in ARDS

Apr 14, 2022

CalciMedica Announces Publication of Results from CARDEA COVID-19 Trial in Critical Care

Apr 12, 2022

Akston Biosciences CEO to Present at the World Vaccine Congress

Apr 7, 2022

Akston Biosciences Doses First Volunteers in Phase II/III Clinical Trial of Low Cost, Shelf Stable COVID-19 Vaccine

Mar 31, 2022

Akston Biosciences Receives Regulatory Approval for Phase II Clinical Trial for Shelf-Stable COVID-19 Vaccine Booster

Mar 29, 2022

Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine

Mar 28, 2022

Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell™ Universal Donor Adult Stem Cell Product

Mar 22, 2022

Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats

Mar 22, 2022

Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing and Controls for Covid-19 Oral Therapeutic

Mar 21, 2022

Nature Paper: BioAge’s Oral Drug Targeting the Aging Immune System Prevents Death From COVID-19 in Aged Mice

Mar 21, 2022

Chimeron Bio Enters Into an Agreement With the NIAID, a Federal Agency, for Pre-clinical Assessment of Its Self-Amplifying COVID-19 Vaccine

Mar 17, 2022

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Mar 17, 2022

Codagenix Intranasal COVID-19 Vaccine Shows Potent Cellular Immune Response Against Conserved Viral Proteins, Indicating Potential for Immunogenicity Against Omicron and Future Variants in Phase 1 Data

Mar 10, 2022

Therapeutic Solutions International Granted Second United States Patent on QuadraMune for Prevention, Inhibition, and Treatment of COVID-19

Mar 10, 2022

Pharmazz Inc. announces FDA clearance of an IND application for a Phase II clinical trial of centhaquine (PMZ-2010) in COVID-19 patients with ARDS

Mar 9, 2022

Romark's Vanguard Co-V Clinical Trial Published in Lancet's eClinicalMedicine

Mar 8, 2022

Angiotensin Therapeutics Inc. anuncia un estudio que usa una proteína ACE2 soluble para la COVID-19 España - español USA - English

Mar 8, 2022

Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19

Mar 7, 2022

Therapeutic Solutions International Announces ApoptoCyte Procedure for Enhancing Stem Cell Activity

Mar 6, 2022

Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing

Mar 2, 2022

BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies

Mar 2, 2022

SAB Biotherapeutics Reports NIH is Discontinuing Phase 3 ACTIV-2 Trial Assessing SAB-185 for Treatment of COVID-19 Due to Declining COVID Hospitalizations

Feb 25, 2022

SAB Biotherapeutics Announces Update to the Phase 3 NIH ACTIV-2 Trial Design Evaluating SAB-185 for Treatment of COVID-19

Feb 24, 2022

Medicago and GSK Announce the Approval by Health Canada of COVIFENZ, an Adjuvanted Plant-Based COVID-19 Vaccine

Feb 24, 2022

Cantex to Expand Development of Its Drug, Azeliragon, Collaborating with Harvard's Wyss Institute, as a Treatment of COVID-19 and Other Inflammatory Lung Diseases

Feb 22, 2022

Sen-Jam Pharmaceutical Partners with Leading Academic Medical Centers in Promising Novel Oral COVID-19 Therapeutic Clinical Trial

Feb 15, 2022

Laurent Pharmaceuticals Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Treatment Candidate in Hospitalized Moderate-to-Severe Patients

Feb 8, 2022

Akston Biosciences Announces Publication in Vaccine of Positive Data for a Room Temperature Protein Subunit COVID-19 Vaccine

Feb 8, 2022

Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)

Feb 8, 2022

Xanadu Bio Obtains Licenses and Options to Novel Platform Technologies from Yale University to Develop an Intranasal SARS CoV-2 mRNA Vaccine Booster Aimed at Inducing Local Mucosal Immunity to Prevent SARS CoV-2 Infection and Virus Transmission

Feb 7, 2022

Therapeutic Solutions International Announces Reduction of COVID-19 Associated Cognitive Decline by QuadraMune Nutraceutical in Animal Model

Feb 3, 2022

Tevogen Bio Announces Positive Safety Data from Second Cohort in Ongoing Proof-of-Concept Clinical Trial of TVGN-489, its Investigational T cell Therapy for Treatment of COVID-19 in High-Risk Patients

Feb 3, 2022

ExThera Medical and Fresenius Medical Care Sign Distribution Agreement for Seraph 100 Blood Purification Device in Mexico

Jan 26, 2022

NanoPass's intradermal delivery platform used in Emergex's next generation COVID-19 vaccination study USA - English USA - English USA - English

Jan 24, 2022

Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test

Jan 24, 2022

SAB Biotherapeutics Reports Positive Phase 2 Virology Data Demonstrating SAB-185 Met Criteria for Advancement to Phase 3 in NIH ACTIV-2 Trial for Treatment of COVID-19

Jan 20, 2022

CalciMedica Initiates CARDEA-Plus: A Clinical Trial of Auxora™ in Patients with Critical COVID-19 Pneumonia

Jan 14, 2022

Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests

Jan 5, 2022

Tevogen Bio Appoints Yale Public Health Dean Dr. Sten H. Vermund, Preeminent Global Expert in COVID-19 and Infectious Disease Epidemiology, to its Innovation and Public Health Advisory Council

Jan 3, 2022

Therapeutic Solutions International Reports Positive Clinical Data on QuadraMune Reduction of SARS-CoV-2 Spike Protein Induced Inflammation

Dec 30, 2021

Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial

Dec 29, 2021

Tevogen Bio Reinforces IP Portfolio With Additional US Patent for Its Investigational T Cell Therapy for Treatment of COVID-19

Dec 28, 2021

Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment

Dec 22, 2021

Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands

Dec 16, 2021

Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate

Dec 15, 2021

Laurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation and Death

Dec 14, 2021

Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19

Dec 14, 2021

Tevogen Bio Presents Data Detailing Immunologic Escape in SARS-CoV-2 Variants Underscoring Criticality of its T Cell Target Tuning Technology and Investigational COVID-19 therapy at ASH 2021

Dec 13, 2021

CEPI Partners with Affinivax to Develop a Novel COVID-19 Vaccine to Target Variants

Dec 13, 2021

Memo Therapeutics AG to Receive CHF 10.5 Million from Swiss Federal Funding Programme to Clinically Develop SARS-CoV-2 Antibody Against COVID-19

Dec 9, 2021

Abpro Reports Its ABP 310 COVID Antibody Retains Neutralization Activity Against the SARS-CoV-2 Omicron Variant

Dec 8, 2021

Tevogen Bio Announces U.S. Patent and Trademark Office Has Granted Patent for Preparation of Tevogen’s SARS-CoV-2 Specific Allogeneic Cytotoxic T Lymphocytes (CTL) and Methods of Treatment Using Tevogen’s Investigational CTL Therapy for COVID-19

Dec 7, 2021

Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate

Dec 3, 2021

Vivera to Provide COVID-19 Testing at No-Cost at Univision Toy Drive

Dec 2, 2021

Vivera Named COVID-19 Testing Partner for the 2021 Indigenous Bowl

Dec 2, 2021

EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement

Nov 26, 2021

Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19

Nov 20, 2021

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

Nov 16, 2021

Recbio Receives Pharmaceutical Production License from Jiangsu Medical Products Administration for Production of COVID-19 Vaccine

Nov 16, 2021

Tevogen Bio Announces First Cohort Dosed in Ongoing Proof of Concept Clinical Trial of TVGN-489, its Investigational T cell Immunotherapy Product for Treatment of COVID-19 in High-Risk Patients

Nov 12, 2021

MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797

Nov 11, 2021

Vivera Pharmaceuticals Offers No-Cost COVID-19 Testing to LAPD and LAFD

Nov 11, 2021

Recbio Announces Promising Preliminary Results From First-in-Human Study of a COVID-19 Vaccine Candidate With Novel Adjuvant BFA03

Nov 8, 2021

Recbio Announces New Study Showing Its COVID-19 Vaccine Induced High Levels of Neutralizing Antibodies against SARS-CoV-2 and Variants of Concern

Nov 1, 2021

7 Hills Pharma Announces the Completion of a Landmark Phase I Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines

Oct 26, 2021

HiberCell and Strasbourg Institute for Precision Medicine Publish Machine Learning Data and Approach on Causal Biology of Severe COVID-19

Oct 12, 2021

Sen-Jam Pharmaceutical Planning to Trial Oral COVID Therapy

Oct 8, 2021

Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine

Oct 6, 2021

Lumen Bioscience Awarded Federal Funding to Advance Covid-19 Antibody Cocktail through Phase 2 Clinical Evaluation

Oct 4, 2021

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

Sep 30, 2021

Curebase Solutions Supports Another InBios FDA Emergency Use Authorization for COVID-19 IgG Antibody Rapid Test

Sep 30, 2021

Laurent Pharmaceuticals Announces Topline Results from its Phase 2 RESOLUTION Clinical Trial of LAU-7b for the Treatment of COVID-19

Sep 29, 2021

Codagenix Presents Positive Phase 1 Data for COVI-VAC Intranasal COVID-19 Vaccine at IDWeek 2021

Sep 24, 2021

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

Sep 22, 2021

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

Sep 22, 2021

COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial

Sep 22, 2021

Codagenix Announces Safety and Immunogenicity Data from Phase 1 COVID-19 Intranasal Vaccine Trial and Intent to Progress to Phase 2/3 Studies

Sep 22, 2021

Model Medicines announces preclinical data in study of orally available lead therapeutic (MDL-001) against COVID-19, in partnership with Scripps Research and Mount Sinai, demonstrating efficacy against primary endpoint

Sep 22, 2021

Therapeutic Solutions International Discovers and Files Patent on Novel Cellular Therapy Combination for Augmentation of Lung Repair in COVID-19 Model

Sep 21, 2021

Rhizen Pharmaceuticals AG Announces First Patient Dosed in a Phase 2 Study of RP7214 in Covid-19 Patients

Sep 14, 2021

CalciMedica Reports Topline Data from the AuxoraTM CARDEA Phase 2 COVID-19 Pneumonia Clinical Trial

Sep 13, 2021

AIVITA Biomedical Announces 96% Immune Response Against SARS-CoV-2 in Phase 2 Clinical Trial of a Personalized Vaccine

Sep 9, 2021

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine

Sep 9, 2021

Tevogen Bio Reaches Major Milestone in Commercial Manufacturing Readiness by Completing the Technology Transfer of its Investigational COVID-19 T Cell Therapy

Sep 1, 2021

Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection

Aug 31, 2021

Tevogen Bio to Initiate Clinical Trial of its Investigational T Cell Therapy for COVID-19 at Thomas Jefferson University

Aug 27, 2021

Airway Therapeutics annonce avoir administré une dose à son premier patient dans le cadre de l'essai de phase 1b de l'AT-100 chez les patients atteints de COVID-19 sévère France - Français USA - English España - español Deutschland - Deutsch

Aug 27, 2021

Airway Therapeutics gibt bekannt, dass der erste Patient in der Phase-Ib-Studie für AT-100 bei Patienten mit schwerem COVID-19 Krankheitsverlauf behandelt wird Deutschland - Deutsch USA - English España - español France - Français

Aug 27, 2021

BioAegis Therapeutics Announces Publication of a Compassionate Use Case Study of a Critical COVID-19 Patient

Aug 26, 2021

Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Severe COVID-19 Patients USA - English España - español France - Français Deutschland - Deutsch

Aug 24, 2021

EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil USA - English Brazil - Português

Aug 24, 2021

EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil España - español Deutschland - English Brazil - Português France - Français Italia - Italiano Deutschland - Deutsch USA - English

Aug 18, 2021

Ginkgo Bioworks Provides First Half 2021 Update

Aug 17, 2021

Numerated Ranks No. 32 on the 2021 Inc. 5000

Aug 12, 2021

Sen-Jam Pharmaceutical Partners With Duke-NUS Medical School for a Phase 2 Trial for a New COVID 19 Treatment

Aug 11, 2021

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19

Aug 9, 2021

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand

Aug 5, 2021

Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine

Aug 2, 2021

SaNOtize inks agreement with Indian biotech Glenmark to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

Jul 28, 2021

Vivera Pharmaceuticals Responds to New Safety Protocols with Expanded Access to COVID-19 Testing, Vaccines, and Personal Protective Equipment

Jul 28, 2021

DiosCURE Announces Exclusive Worldwide License Agreement for Best-in-Class Nanobodies Against COVID-19

Jul 26, 2021

Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets

Jul 22, 2021

eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent

Jul 21, 2021

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Jul 19, 2021

Adagio Therapeutics Appoints David Hering, Global COVID-19 Vaccine Expert, as Chief Operating Officer

Jul 19, 2021

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE USA - English USA - English

Jul 19, 2021

Selva to Present Preclinical Data at ASV 2021 Demonstrating Prophylactic and Therapeutic Oral Dosing of SLV213 for COVID-19 Protected Lungs from SARS-CoV-2-Induced Damage

Jul 19, 2021

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE

Jul 17, 2021

ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabotegravir/rilpivirine) can be successfully implemented in broad range of US healthcare practices, even during COVID-19

Jul 14, 2021

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Jul 12, 2021

Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients and Receives Additional Public Funding of €45 Million

Jul 12, 2021

Tevogen Bio Announces FDA Clearance of Investigational New Drug (IND) Application For its Cytotoxic T Cell Therapy for COVID-19

Jul 8, 2021

Akston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate

Jul 8, 2021

Exscientia Accelerates COVID-19 Drug Discovery Using AI

Jul 6, 2021

Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate

Jul 6, 2021

Tetherex Pharmaceuticals Signs Exclusive Worldwide License with Mayo Clinic for Development and Commercialization of a Novel Single-Cycle Adenovirus Vaccine Platform

Jun 30, 2021

Vivera Pharmaceuticals Partners with Areum Bio LLC and Access Bio, Inc. to Expand the National Distribution of Emergency Use Authorized COVID-19 Rapid Tests

Jun 28, 2021

Treos Bio Announces the Publication of Preclinical Data in Frontiers in Genetics Showing its COVID-19 Peptide Vaccine Mimics the Diversity of T Cell Immunity Produced by Natural SARS-CoV-2 Infection

Jun 23, 2021

SaNOtize Obtains Health Canada Approval to Begin Enrolment for Phase III Trials for COVID-19 Anti-Viral Treatment

Jun 23, 2021

Qu Biologics Receives Additional Funding to Accelerate Clinical Development of Qu’s First-in-Class Immunotherapeutic for COVID-19 Prevention and Treatment

Jun 22, 2021

Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

Jun 15, 2021

Ashvattha Therapeutics Announces Positive Interim Data from Ongoing Phase 2 PRANA Clinical Study of OP-101 in Severe COVID-19 Patients

Jun 9, 2021

Selva Announces SLV213, a Potential Oral COVID-19 Treatment, Has Broad Activity Against SARS-CoV-2 Variants of Concern

Jun 8, 2021

ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19

Jun 7, 2021

Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel USA - English USA - English USA - English

Jun 7, 2021

Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel

Jun 7, 2021

Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel Israel - English Israel - English

May 25, 2021

NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)

May 25, 2021

Elixirgen Therapeutics Announces Dosing of First and Second Participants in its COVID-19 Vaccine Phase 1/2 Clinical Trial at Fujita Health University

May 25, 2021

Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M. Church, PhD

May 20, 2021

Laurent Pharmaceuticals Completes Patients Enrollment in Phase 2 Study of LAU-7b for the Treatment of COVID-19

May 18, 2021

Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate

May 13, 2021

ILC Therapeutics Announces Board Changes and Funding Round to Accelerate Covid-19 Drug

May 11, 2021

HiFiBiO Therapeutics Announces Publication in Nature Communications on its SARS-CoV-2 Neutralizing Monoclonal Antibody

May 5, 2021

Adagio Therapeutics Announces ADG20 Phase 1 Data and Initiation of Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

May 4, 2021

Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review

May 3, 2021

Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide

Apr 29, 2021

Partner Therapeutics Initiates Patient Enrollment in Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in High-risk Non-hospitalized COVID-19 Patients (SCOPE)

Apr 29, 2021

Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients

Apr 29, 2021

Atea Pharmaceuticals Announces First Patient Dosed in Global Phase 3 MORNINGSKY Trial of AT-527 for Treatment of COVID-19

Apr 28, 2021

NeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia

Apr 21, 2021

SAB Biotherapeutics Doses First Patient with SAB-185 for the Treatment of COVID-19 in NIH’s ACTIV-2 Phase 2/3 Clinical Trial

Apr 20, 2021

Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19

Apr 20, 2021

Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19

Apr 19, 2021

Adagio Therapeutics Announces $336 Million Series C Financing to Support Rapid Advancement of Novel ADG20 Antibody for the Treatment and Prevention of COVID-19

Apr 19, 2021

Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19

Apr 16, 2021

Bold Therapeutics' BOLD-100 Effective In Vitro Against COVID-19 Variants

Apr 15, 2021

Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19

Apr 14, 2021

Cyclica Teams Up with Top-Tier Academic Institutions to Identify a Repurposed COVID Drug

Apr 14, 2021

Romark Announces Initial Results Of Phase 3 Clinical Trial Of NT-300 Tablets For The Treatment Of COVID-19

Apr 13, 2021

Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19

Apr 12, 2021

Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine

Apr 12, 2021

Airway Therapeutics anuncia aceitação pela FDA de IND para a segunda indicação de AT-100 em pacientes de COVID-19 em estado grave Brazil - Português France - Français USA - English Deutschland - Deutsch Latin America - español

Apr 12, 2021

Airway Therapeutics annonce que la FDA a accepté la demande de NMR pour la deuxième indication de l'AT-100 chez les patients atteints de COVID-19 grave France - Français Brazil - Português USA - English Deutschland - Deutsch Latin America - español

Apr 12, 2021

Airway Therapeutics Announces FDA Acceptance of IND for AT-100's Second Indication in Severe COVID-19 Patients USA - English Deutschland - Deutsch Latin America - español España - español

Apr 12, 2021

Airway Therapeutics anuncia que la FDA aceptó la aplicación de Nuevo Fármaco en Investigación (IND) para la segunda indicación de AT-100 en pacientes graves con COVID-19 USA - English Brazil - Português USA - English Deutschland - Deutsch

Apr 12, 2021

NxGen MDx Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

Apr 12, 2021

Airway Therapeutics anuncia aceitação pela FDA de IND para a segunda indicação de AT-100 em pacientes de COVID-19 em estado grave Brazil - Português USA - Français India - English USA - Deutsch Latin America - español

Apr 12, 2021

Airway Therapeutics annonce que la FDA a accepté la demande de NMR pour la deuxième indication de l'AT-100 chez les patients atteints de COVID-19 grave USA - Français Brazil - Português India - English USA - Deutsch Latin America - español

Apr 12, 2021

Airway Therapeutics anuncia que la FDA aceptó la aplicación de Nuevo Fármaco en Investigación (IND) para la segunda indicación de AT-100 en pacientes graves con COVID-19 Latin America - español USA - Français Brazil - Português India - English USA - Deutsch

Apr 9, 2021

FidaLab Announces Partnership With Ginkgo Bioworks to Scale COVID Response Through Pooled Testing in K-12 Schools

Apr 9, 2021

Rapid Dx Laboratory Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

Apr 8, 2021

Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.

Apr 6, 2021

UNION therapeutics' COVID-19 candidates found to be well tolerated in Phase 1 Lancet publication

Apr 6, 2021

Sound Pharmaceuticals awarded $3.1M NIH grant to test SPI-1005 in COVID-19

Mar 31, 2021

Clinical Reference Laboratory and Ginkgo Bioworks Partner to Expand COVID-19 Pooled Testing in K-12 Schools

Mar 30, 2021

Olive Labs Inc. Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

Mar 30, 2021

CQuentia Announces Partnership with Ginkgo Bioworks to Scale COVID Prevention Response through Pooled Testing in K-12 Schools

Mar 29, 2021

NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19

Mar 26, 2021

NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure

Mar 24, 2021

Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate

Mar 24, 2021

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19

Mar 22, 2021

BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging, a Key Cause of Morbidity and Mortality in Older Patients

Mar 19, 2021

UPDATE: NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COVID-19 (AVICOVID-2)

Mar 16, 2021

Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate

Mar 16, 2021

CORAT Therapeutics GmbH obtained regulatory authorization for clinical phase Ib/II trial with the SARS-CoV-2 neutralizing human antibody COR-101

Mar 16, 2021

Cytocom Receives FDA Clearance of IND for Phase 2 Clinical Trial of CYTO-205 as Treatment for COVID-19

Mar 15, 2021

UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19

Mar 15, 2021

Tevogen Bio Announces Partnership With BioCentriq, New Jersey Innovation Institute’s Pioneering Cell and Gene Therapy Center, to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19

Mar 15, 2021

BioAegis Therapeutics Completes Recruitment for Phase 2 Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment

Mar 9, 2021

Viriom and Chromis publish results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021

Mar 8, 2021

Aligos Therapeutics Presents Nonclinical Data for its COVID-19 Therapeutic in Development at the 2021 Conference on Retroviruses and Opportunistic Infections

Mar 8, 2021

ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.

Mar 6, 2021

Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

Mar 4, 2021

Brii Biosciences Antibody Combination Will Not Progress into a Phase 3 Study Evaluating the Treatment of SARS-CoV-2 in Hospitalized Patients

Mar 3, 2021

eXIthera Pharmaceuticals Announces FDA Acceptance of IND Application for Phase 2 Trial of EP-7041 for Thrombosis Prevention in COVID-19 Patients

Feb 26, 2021

Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial

Feb 25, 2021

AIVITA Biomedical Completes Phase 1 Study of Personalized COVID-19 Vaccine Candidate, AV-COVID-19

Feb 23, 2021

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint

Feb 23, 2021

NeuroRx Announces that ZYESAMI (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint

Feb 22, 2021

Hope Biosciences Stem Cell Research Foundation Secures Authorization for “Long Haulers” COVID Study

Feb 22, 2021

UNI91103, developed by UNION therapeutics A/S, selected as first agent for prophylactic COVID-19 "PROTECT-V" study in high-risk patients

Feb 19, 2021

Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan

Feb 16, 2021

Adagio Therapeutics Announces Dosing of First Patient in Phase 1 Trial of ADG20, its Lead Monoclonal Antibody Candidate for the Treatment and Prevention of COVID-19

Feb 16, 2021

Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of CYTO-205 for the Treatment of COVID-19

Feb 16, 2021

ReAlta Life Sciences Doses First Subject in Phase 1 Healthy Volunteers Study of RLS-0071

Feb 11, 2021

ImmunityBio and NantKwest Announce FDA Authorization to Study hAd5 T-Cell COVID-19 Vaccine for Combination of Subcutaneous, Oral and Sublingual Boost to Induce T-Cell, Mucosal, and Antibody Immunity

Feb 9, 2021

NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19

Feb 4, 2021

Angiotensin Therapeutics Inc. announces publication of a Novel Approach to COVID 19 Therapy

Feb 3, 2021

NeuroRx Initiates Phase 2/3 Study of Inhaled ZYESAMI™ for Severe COVID-19 with UCI Health

Feb 3, 2021

AuraVax Therapeutics Enters into Exclusive License Agreement with the University of Houston for Intranasal Vaccine and Therapeutics Technology Platform

Feb 2, 2021

Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools

Feb 2, 2021

Selva Therapeutics Announces Successful Completion of Phase 1 Clinical Study of SLV213, a Potential Oral Treatment for COVID-19

Feb 2, 2021

MAX BioPharma Announces Key Discoveries Regarding Oxysterol Drug Candidates for Targeting Covid-19

Feb 1, 2021

Codagenix's CEO to Present Update on COVI-VAC During New York Academy of Sciences Event, "Quest for a COVID-19 Vaccine"

Feb 1, 2021

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

Feb 1, 2021

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

Feb 1, 2021

Positive data from Phase II study ATTRACT in patients with COVID-19 published online: Vicore Pharma Holding

Jan 27, 2021

AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19

Jan 26, 2021

AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%

Jan 25, 2021

Adagio Therapeutics Publishes Preclinical Data in Science Demonstrating Best-in-Class Breadth and Potency Against SARS-CoV-2, Including Known Circulating Resistance Variants, and a Range of Pre-Emergent Coronaviruses

Jan 25, 2021

Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative

Jan 25, 2021

Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19

Jan 21, 2021

AbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for Residents

Jan 19, 2021

ImmunityBio Announces Phase I Trial of COVID-19 Vaccine Candidate in South Africa as New Variants of SARS-CoV-2 Spread

Jan 18, 2021

Global Human Microbiome Therapeutics Market Report 2020: COVID-19 Pandemic has Decreased Short-term Potential Growth Opportunities

Jan 13, 2021

AuraVax Therapeutics Enters into Exclusive License Agreement with Massachusetts General Hospital for Intranasal Vaccine and Therapeutics Platform

Jan 12, 2021

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  

Jan 11, 2021

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI™ (RLF-100™: aviptadil) in the I-SPY COVID-19 Trial

Jan 11, 2021

Codagenix and Serum Institute of India Initiate Dosing in Phase 1 Trial of COVI-VAC, a Single Dose, Intranasal, Live Attenuated Vaccine for COVID-19

Jan 7, 2021

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

Jan 6, 2021

Bold Therapeutics Secures Funding to Prepare BOLD-100 for COVID-19 Clinical Trials

Jan 5, 2021

Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine

Jan 4, 2021

ImmunityBio Simulates SARS-CoV-2 Spike Protein Binding Using Molecular Dynamics

Dec 31, 2020

EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19

Dec 30, 2020

NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

Dec 24, 2020

Inotrem’s COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French Government’s Clinical Trial Council

Dec 23, 2020

Ginkgo Bioworks Launches COVID-19 Pooled Classroom Testing Pilot for K-12 Schools

Dec 23, 2020

EOM Pharmaceuticals Announces Its Pre-IND Meeting Request With U.S. FDA to Evaluate Plans for a Phase 2 Clinical Trial of Its Investigational Dual-Acting, Broad-Spectrum Immunomodulator in COVID-19 Patients

Dec 22, 2020

AMO Pharma Announces Initiation of Pivotal REACH-CDM Clinical Trial for AMO-02 in Treatment of Congenital Myotonic Dystrophy

Dec 21, 2020

AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico

Dec 21, 2020

Inotrem announces Data Monitoring Committee (DMC) recommends continuation of Phase IIa study of nangibotide for the treatment of severe forms of COVID-19

Dec 18, 2020

Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu’s Novel Immunotherapy Platform

Dec 18, 2020

Enesi Pharma and Imperial College London Collaborate to Develop Thermostable RNA Vaccines with Potential to Eliminate Cold Chain and Transform Global Vaccination Logistics for COVID-19

Dec 17, 2020

Brii Biosciences Provides Corporate Update on Progress Against Strategic RandD Priorities

Dec 16, 2020

Abpro Announces Initiation of Phase 2/3 Registrational Studies of its Neutralizing Antibody Therapeutic ABP 300 for the Treatment of COVID-19

Dec 15, 2020

Non-Traditional Clinical Trial Sites Powered by the Curebase System Support Emergency Use Authorization of New Rapid COVID-19 Test

Dec 14, 2020

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Dec 14, 2020

Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19

Dec 10, 2020

ImmunityBio’s hAd5 T-Cell COVID-19 Vaccine Candidate Shows Complete Protection of Airways in Non-Human Primates

Dec 10, 2020

Ginkgo Bioworks and Octant Partner to Expand COVID-19 Testing Capacity using Next-Generation Sequencing Technology

Dec 9, 2020

Immunomic Therapeutics Executives and Board Members of WhyWeVax™ Discuss COVID-19 Vaccine Issues with Fox News and CDC’s ACIP Committee

Dec 8, 2020

Sojournix Advances Phase 2 Clinical Trial of SJX‑653 for Menopausal Hot Flashes

Dec 8, 2020

Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19

Dec 7, 2020

NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

Dec 4, 2020

Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates

Dec 3, 2020

Memo Therapeutics AG’s Antibody Against SARS-CoV-2 Demonstrates Potent Therapeutic and Prophylactic Activity in Advanced COVID-19 Disease Model

Nov 30, 2020

NeoImmuneTech Announces First Patient Dosed in Phase 1 Study of NT-I7 (efineptakin alfa) in Adults with Mild COVID-19

Nov 30, 2020

SAB Biotherapeutics Awarded $57.5M from BARDA and U.S. Department of Defense for Manufacturing of SAB-185 for the Treatment of COVID-19

Nov 25, 2020

Ginkgo Bioworks To Expand Biosecurity and Pandemic Response Platform with $1.1B Federal Loan

Nov 24, 2020

NeuroRx and Relief announce initial successful results from expanded access use of RLF-100™ (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients

Nov 24, 2020

NeuroRx and Relief announce initial successful results from expanded access use of RLF-100 (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients

Nov 23, 2020

BERG And AdventHealth Announce New Partnership To Decrease Mortality Rate Of COVID-19 Patients Throughout Hot Zones Across USA

Nov 20, 2020

AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19

Nov 18, 2020

Adagio Therapeutics COVID-19 Antibody Demonstrates Best-in-Class Breadth and Potency Against a Range of Coronaviruses that Pose Human Threat

Nov 16, 2020

Abpro Announces Peer-Reviewed Publication Demonstrating Efficacy of its Neutralizing Antibody Therapeutic Against COVID-19

Nov 15, 2020

BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator

Nov 13, 2020

NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

Nov 13, 2020

NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100 for Critical COVID-19 with Respiratory Failure

Nov 12, 2020

CORRECTING and REPLACING Medicago and GSK Announce Start of Phase 2/3 Clinical Trials of Adjuvanted COVID-19 Vaccine Candidate

Nov 12, 2020

Selva Therapeutics Announces First Dosing in Phase 1 Clinical Study of SLV213, a Potential Oral Treatment for COVID-19

Nov 11, 2020

Medicago Announces Positive Phase 1 Results for Its COVID-19 Vaccine Candidate

Nov 10, 2020

TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response

Nov 10, 2020

ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study

Nov 9, 2020

AbCellera-Discovered Antibody Receives U.S. FDA Emergency Use Authorization as a Monotherapy for the Treatment of COVID-19

Nov 9, 2020

ImmunityBio’s hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2

Nov 9, 2020

7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines

Nov 6, 2020

Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round

Nov 5, 2020

NeuroRx and Relief Therapeutics announce continuation of RLF-100™ trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020

Nov 5, 2020

NeuroRx and Relief Therapeutics announce continuation of RLF-100 trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020

Nov 2, 2020

CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure

Oct 27, 2020

Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Oct 27, 2020

Olatec Therapeutics Enrolls its First Patients in a Phase 2 Clinical Trial in COVID-19 with its Selective NLRP3 Inhibitor, Oral Dapansutrile

Oct 26, 2020

Ginkgo Bioworks Secures Access to SARS-CoV-2 Rapid Antigen Test With Goal of Acquiring and Distributing Up To 50 Million Tests

Oct 26, 2020

HiFiBiO Therapeutics Completes First Cohort of a Phase I Study of its SARS-CoV-2 Neutralizing Antibody for the Treatment and Prevention of COVID-19

Oct 23, 2020

PMI Announces Medicago to Supply Up to 76 Million Doses of Its Plant-Derived COVID-19 Vaccine Candidate

Oct 22, 2020

Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19

Oct 22, 2020

Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients

Oct 21, 2020

ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2

Oct 21, 2020

Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19

Oct 20, 2020

TScan Therapeutics Announces Publication of Study in Immunity Highlighting the Discovery of Novel T Cell Targets in COVID-19

Oct 20, 2020

Abpro Announces Completion of Dosing in Phase 1 Study of its Neutralizing Antibody Therapeutic, ABP 300 for Treatment of COVID-19

Oct 15, 2020

FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity

Oct 14, 2020

Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates

Oct 13, 2020

NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19

Oct 13, 2020

NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100 (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19

Oct 12, 2020

Review Article, Authored by ZyVersa Therapeutics' Esteemed Scientific Advisors, Demonstrates the Role of Inflammasomes in the Exacerbated Immune Response Associated with COVID-19 Infection (Just Published in Frontiers in Immunology)

Oct 12, 2020

AuraVax Therapeutics Enters into Exclusive License Option Agreement with the University of Houston for Intranasal Vaccine Platform

Oct 7, 2020

Vivera Pharmaceuticals Selected to Screen Travellers to the UAE for COVID-19 USA - English USA - English

Oct 7, 2020

ILC Therapeutics Announces ‘Significant’ COVID-19 Drug Breakthrough

Oct 7, 2020

Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro

Oct 7, 2020

Mapi Pharma Announces Commissioning of a Vaccine Production Facility to Support the Supply of COVID-19 Vaccines to Israel and EU Countries

Oct 1, 2020

Vivera Pharmaceuticals Announces Two New Diagnostic Tests for COVID-19

Sep 28, 2020

COVISTAT, a Subsidiary of Ensysce Biosciences Inc, a California Based Company With a Mission to Solve the Opioid Crisis, Is Commencing Phase 1 Study of Novel COVID-19 Treatment

Sep 25, 2020

Clover Biopharmaceuticals Announces Formation of a Global Scientific Advisory Board for its COVID-19 Vaccine Program

Sep 25, 2020

Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate

Sep 24, 2020

THE LANCET publishes promising data of APEIRON's APN01 (rhsACE2) to treat COVID-19 in named patient use

Sep 24, 2020

OncoImmune’s SACCOVID™ (CD24Fc) Exhibits Superb Therapeutic Efficacy—A Potential Breakthrough in Treating Severe and Critical COVID-19

Sep 23, 2020

NeuroRx submits request for Emergency Use Authorization for RLF-100™ (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy

Sep 23, 2020

NeuroRx submits request for Emergency Use Authorization for RLF-100 (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy

Sep 22, 2020

Serum Institute of India Initiates Manufacturing of Codagenix's Intranasal Live-Attenuated COVID-19 Vaccine Candidate

Sep 21, 2020

Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research

Sep 18, 2020

Axon Neuroscience to launch world's first crowdfunded vaccine against COVID-19 English Français Deutsch

Sep 18, 2020

Axon Neuroscience bringt weltweit ersten Crowdfunding-Impfstoff gegen COVID-19 auf den Markt Deutsch Français English

Sep 18, 2020

Axon Neuroscience lancera le premier vaccin financé par le public contre la COVID-19 au monde France - Français Deutschland - Deutsch USA - English

Sep 16, 2020

Interim Data Reported for AbCellera-Discovered COVID-19 Antibody in Phase 2 Clinical Trials

Sep 14, 2020

Blade Therapeutics Reaches Enrollment Goal for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients With COVID-19 Pneumonia

Sep 10, 2020

Totient Partners with Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts

Sep 9, 2020

OncoImmune, Inc. Raises $56 Million Series B Financing for Novel Cancer and COVID-19 Therapeutics

Sep 9, 2020

Vivera Pharmaceuticals Announces New Diagnostic Test Solution For COVID-19

Sep 8, 2020

BERG's Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population

Sep 1, 2020

Elixirgen Therapeutics planning to begin Phase I/II Clinical Trials of its COVID-19 Vaccine Candidate EXG-5003 at Fujita Health University

Aug 31, 2020

FDA allows Sound Pharmaceuticals to test SPI-1005 as a novel treatment for COVID-19

Aug 31, 2020

Ashvattha Therapeutics Subsidiary Orpheris Enrolls First Patients in Phase 2 PRANA Clinical Study Evaluating OP-101 for Severe COVID-19

Aug 27, 2020

Laurent Pharmaceuticals Receives Approval from FDA to Initiate its COVID-19 Phase 2 Clinical Trial in the United States

Aug 27, 2020

Vaccitech receives government grant for COVID-19 vaccine research

Aug 26, 2020

HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for the Treatment of COVID-19 Patients

Aug 25, 2020

Partner Therapeutics Initiates Patient Enrollment in U.S. Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in COVID-19 Patients

Aug 25, 2020

EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics USA - English España - español Deutschland - Deutsch France - Français

Aug 24, 2020

NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics

Aug 24, 2020

UNION therapeutics A/S completes dosing of healthy volunteers with UNI911 (inhaled niclosamide) for COVID-19

Aug 21, 2020

SAB Biotherapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of SAB-185 for the Treatment of COVID-19

Aug 20, 2020

Adaptive Phage Therapeutics Receives Department of Defense Award for Development of COVID-19 Vaccine

Aug 19, 2020

Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Announce Collaboration to Develop Monoclonal Antibody, Natural Killer Cell Combination Approach to Treating COVID-19

Aug 17, 2020

HiFiBiO Therapeutics Collaborates with Coronavirus Immunotherapy Consortium in the Fight Against COVID-19

Aug 14, 2020

Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19 USA - English USA - English

Aug 13, 2020

UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc.

Aug 13, 2020

Vivera Pharmaceuticals announces one-step COVID-19 testing cartridge

Aug 12, 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

Aug 11, 2020

SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-185 for the Treatment and Prevention of COVID-19

Aug 11, 2020

AUM LifeTech awarded NIH grant to develop HIV therapy using RNA targeting technology, commits additional resources to COVID-19 research

Aug 11, 2020

Romark Initiates New Phase 3 Clinical Trial Of NT-300 For The Treatment Of COVID-19

Aug 10, 2020

GigaGen Announces Publication of Research Describing a New Class of Drugs, Recombinant Hyperimmunes, Including its Novel COVID-19 Therapy, GIGA-2050

Aug 6, 2020

SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program

Aug 5, 2020

BioAegis Therapeutics Initiates Phase 2 Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment

Aug 5, 2020

Small NJ Biotech Firm, BioAegis Therapeutics, Accelerating Multiple Clinical Trial Submissions for Severe COVID-19 Pneumonia Patients

Aug 4, 2020

Partner Therapeutics Announces $35 Million Contract with U.S. Department of Defense for Advanced Development and Emergency Use of Leukine (rhuGM-CSF) for COVID-19 Acute Hypoxemic Respiratory Failure (AHRF)

Aug 3, 2020

AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database

Aug 3, 2020

ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins

Aug 3, 2020

Calidi Biotherapeutics Announces FDA Approval for COVID-19 Treatment Manufactured by Partner: Personalized Stem Cells

Jul 30, 2020

Sound Pharmaceuticals files IND to test SPI-1005 in Phase 2 COVID-19 trials

Jul 30, 2020

Vituity and GEn1E Lifesciences Announce Strategic Partnership

Jul 28, 2020

ReAlta Life Sciences Announces U.S. FDA Clearance of First Investigational New Drug Application for RLS-0071

Jul 27, 2020

NeoImmuneTech Announces FDA Approval to Proceed with Second Study of NT-I7 (efineptakin alfa) in Adult COVID-19 Patients

Jul 27, 2020

AI Therapeutics Announces Start of Phase II Trial of LAM-002A (apilimod dimesylate) for Treatment of COVID-19 Patients

Jul 23, 2020

Inotrem Receives Clearance From French, Belgian And US Authorities to Launch a Phase II Clinical Trial Aimed at Assessing Nangibotide in Mechanically Ventilated Patients With COVID-19

Jul 21, 2020

Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Jul 21, 2020

Selva Therapeutics Announces $3 Million Series A Financing to Advance a Novel Broad Spectrum Antiviral for Infectious Diseases, Including COVID-19

Jul 20, 2020

Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) - Featuring Medicago, Moderna and Novavax Among Others - ResearchAndMarkets.com

Jul 20, 2020

Kedrion Biopharma forms research partnership with Columbia University Irving Medical Center to support development of new IgG therapy for COVID-19

Jul 16, 2020

NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19

Jul 16, 2020

Centivax Antibody Effective in Reducing COVID-19 Lung Damage, Virus Levels and Symptoms as Both Therapeutic and Preventative in Healthy and Immunocompromised Hamsters; Confirmed by Multiple National Laboratories

Jul 15, 2020

NeoImmuneTech Announces Clearance for Investigational New Drug Application of NT-I7 (efineptakin alfa) in Adults with Mild COVID-19

Jul 15, 2020

ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production

Jul 15, 2020

BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment

Jul 14, 2020

Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate

Jul 14, 2020

Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant

Jul 9, 2020

Harbour BioMed Raises $102.8M in Series C Financing to Accelerate Development of Its Innovative Portfolio of Next Generation Biologics

Jul 8, 2020

CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate

Jul 8, 2020

Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines

Jul 7, 2020

Ridgeback Biotherapeutics Announces Potential COVID-19 Treatment EIDD-2801 Will Leverage Innovative Testing Platform AGILE for Phase 2 Trial

Jul 7, 2020

7 Hills Pharma Announces Positive Data With Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines

Jul 6, 2020

Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos' Cord Blood T-Regulatory Cells USA - English USA - English

Jul 2, 2020

EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome

Jul 1, 2020

AIVITA Biomedical CEO Hans Keirstead Named to “20 in 2020” by Consulate General of Canada for Contributions to COVID-19 Research

Jun 30, 2020

Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV

Jun 29, 2020

Health Canada Allows COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma's Oxygen Therapeutic in Phase IIa Clinical Trial

Jun 29, 2020

Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial of CYTO-201 in COVID-19 Patients

Jun 29, 2020

PEEL Therapeutics Announces Possible New Treatment for COVID-19

Jun 26, 2020

Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using Mesenchymal Stem Cells (MSCs) as a Prophylactic Against COVID-19

Jun 25, 2020

Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials

Jun 23, 2020

Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19

Jun 23, 2020

BioAegis Therapeutics Completes Over-Subscribed Financing for COVID-19 Trial

Jun 19, 2020

Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate

Jun 19, 2020

Ridgeback Biotherapeutics Announces Launch of Phase 2 Trials Testing EIDD-2801 as Potential Treatment for COVID-19

Jun 18, 2020

Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19

Jun 18, 2020

Ginkgo Bioworks Launches Concentric by Ginkgo to Help Enable Large-Scale COVID-19 Testing

Jun 17, 2020

BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory's Summit Supercomputer in the Fight Against COVID-19

Jun 17, 2020

CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program

Jun 16, 2020

Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial

Jun 15, 2020

Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine

Jun 15, 2020

7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference

Jun 14, 2020

OncoImmune, Inc. Reports Progress on its Phase III Clinical Trial testing CD24Fc for Severe and Critical COVID-19

Jun 12, 2020

Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology

Jun 11, 2020

Lyndra Therapeutics Achieves Critical Milestones Despite COVID-19 Headwinds

Jun 11, 2020

Relief Therapeutics and NeuroRx Expand Clinical Trial Evaluating RLF-100 in Critically Ill COVID-19 Patients With Respiratory Failure to Houston Methodist Hospital

Jun 11, 2020

Bold Therapeutics Expands COVID-19 Consortium

Jun 10, 2020

Vivera Pharmaceuticals Files First of Two US Made COVID-19 Antibody Tests

Jun 9, 2020

Leading BioSciences Teams with Donnelley Financial Solutions to Create Innovative Study Tool for Clinical Trial Monitoring During COVID-19 Pandemic

Jun 8, 2020

SAB Biotherapeutics President and CEO Eddie J. Sullivan, PhD, Featured on COVID-19 Panel at BIO Digital 2020

Jun 5, 2020

AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19

Jun 4, 2020

Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003

Jun 4, 2020

Memo Therapeutics AG Identifies Potent SARS-CoV-2-Neutralizing Antibodies From the Blood of Recovered COVID-19 Patients

Jun 2, 2020

Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress

Jun 2, 2020

Cellenkos Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome USA - English USA - English

Jun 2, 2020

Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine

Jun 1, 2020

AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment

May 29, 2020

Pear Therapeutics to Release Pear-004 to Help People Living with Schizophrenia During the COVID-19 Crisis

May 28, 2020

MD Anderson Cancer Center Now Enrolling Patients in Rafael Pharmaceuticals’ Phase 2 Clinical Trial of CPI-613 (devimistat) for Relapsed or Refractory Burkitt’s Lymphoma/Leukemia

May 28, 2020

Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine in Respiratory Illness in Patients with COVID-19 at Singapore General Hospital

May 28, 2020

SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel COVID-19 Therapeutic Candidate

May 28, 2020

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

May 28, 2020

Ashvattha Therapeutics Subsidiary Orpheris Announces FDA Agreement to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients

May 28, 2020

Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESARTM Technology

May 27, 2020

ImmunityBio and NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine

May 27, 2020

CEPI Announces COVID-19 Vaccine Development Partnership With Clover Biopharmaceuticals’ Australian Subsidiary

May 26, 2020

Datatrak International, Inc. Partners with Renibus Therapeutics, Inc. for Upcoming COVID-19 Clinical Trial

May 23, 2020

Hope Biosciences Stem Cell Research Foundation Completes First Treatments for COVID-19

May 23, 2020

Rafael Pharmaceuticals Receives Approvals to Open Trial Sites in India and Canada for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

May 21, 2020

Hope Biosciences Announces Third FDA-approved Clinical Trial for COVID-19

May 21, 2020

OncoImmune Starts Phase III Clinical Trial Testing the Power of Dampening Inflammation to Virus-induced Cellular Injury in Severe COVID-19 Patients

May 21, 2020

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and Multiple Myeloma

May 21, 2020

Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks

May 20, 2020

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing

May 16, 2020

CERESPIR INCORPORATED Identifies Possible Link Between COVID-19 Induced Brain Inflammation and Acute Respiratory Stress Syndrome Via Breakdown of the Blood-Brain Barrier

May 15, 2020

Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study

May 14, 2020

Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19

May 13, 2020

Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for Protection Against COVID-19

May 9, 2020

Laurent Pharmaceuticals Joins Battle Against COVID-19

May 9, 2020

Immunomic Therapeutics Forms Collaboration with EpiVax and PharmaJet to Develop Novel Vaccine Candidate Against COVID-19 Using Its Investigational UNITE Platform

May 8, 2020

OncoImmune Receives FDA Approval for COVID-19 Clinical Trial

May 7, 2020

Leading BioSciences Announces Potential for Investigational Drug LB1148 to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients

May 7, 2020

ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19

May 6, 2020

Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19

May 6, 2020

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial

May 6, 2020

Galecto Advances Phase 2b Study of GB0139 in Idiopathic Pulmonary Fibrosis Recruitment Remains on Track Despite COVID-19 Crisis

May 5, 2020

AUM LifeTech and AUM BioTech Launch "Knockdown Coronavirus"

May 4, 2020

Appello del Board dell'Associazione dei produttori di abbigliamento turchi (TGSD) ai marchi globali in merito alla lotta contro la COVID-19 USA - English Italia - Italiano USA - English France - Français

May 3, 2020

AbCellera Receives $175.6 Million from the Government of Canada to Discover Solutions for COVID-19 and Build a Manufacturing Facility for Antibody Drugs

May 2, 2020

APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19

May 1, 2020

ImmunityBio Combines Supercomputing Power With Microsoft Azure to Target Infection “Doorway” of the Coronavirus

Apr 30, 2020

Integral Molecular Develops Test for Neutralizing Antibodies in COVID-19 Patients and Clinical Trials

Apr 29, 2020

Chimerix, Exclusive Licensee of Cantex' Lead Product DSTAT, has Announced Initiation of a Phase 2/3 Study of DSTAT, Formerly Known as CX-01, in Acute Lung Injury for Patients with Severe COVID-19

Apr 28, 2020

Worldwide Respiratory Infection Diagnostic Markets 2020-2024 - Mammoth Biosciences Announces Rapid, CRISPR-based COVID-19 Diagnostic

Apr 27, 2020

ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and care during the pandemic

Apr 27, 2020

Romark Initiates Phase 3 Clinical Trials Of NT-300 For COVID-19

Apr 24, 2020

Recursion Releases First Open-Source Morphological Imaging Dataset on SARS-CoV-2 Virus

Apr 23, 2020

Immunomic Therapeutics Announces Close of $61.3M Financing

Apr 21, 2020

ReAlta Life Sciences Closes $14 Million Series A2 Financing to Support Transition into a Clinical Organization

Apr 16, 2020

SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA

Apr 16, 2020

How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic

Apr 15, 2020

Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19

Apr 15, 2020

Bold Therapeutics and the University of Ottawa Initiate Research Partnership to Study BOLD-100 in the Treatment of COVID-19

Apr 15, 2020

Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response

Apr 15, 2020

Khondrion highlights potential role of inflammatory lipid modulator prostaglandin E2 in COVID-19 disease and proposes potential treatment pathway with sonlicromanol

Apr 10, 2020

Axon Neuroscience hat vielversprechenden Impfstoff gegen COVID-19 in der Entwicklung Deutsch English Français

Apr 9, 2020

Axon Neuroscience Has a Promising Peptide Vaccine Against COVID-19 in Development English Français Deutsch

Apr 9, 2020

AXON Neuroscience développe un vaccin prometteur à base de peptides contre la COVID-19 Français English Deutsch

Apr 7, 2020

EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries USA - English Deutschland - Deutsch

Apr 6, 2020

FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Potential Treatment for COVID-19

Apr 2, 2020

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

Apr 2, 2020

Ansun Biopharma gibt positive Ergebnisse der forschungsinitiierten Studie zur Behandlung des neuartigen COVID-19 bekannt

Apr 2, 2020

Ansun Biopharma anuncia resultados positivos del ensayo iniciado por el investigador del nuevo tratamiento COVID-19

Apr 2, 2020

Ansun Biopharma annonce les résultats positifs d'un essai initié par l'investigateur sur un nouveau traitement du COVID-19

Apr 2, 2020

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment English Français Deutsch español

Apr 2, 2020

SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS

Apr 2, 2020

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment USA - English USA - Français USA - Deutsch USA - español

Apr 1, 2020

Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of COVID-19

Apr 1, 2020

EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

Mar 31, 2020

Primmune Therapeutics Announces the Selection of PRTX007 as Its Clinical Development Candidate for COVID-19 and Oncology Indications

Mar 31, 2020

Kleo Pharmaceuticals Enters into Research Collaboration with Green Cross LabCell (GCLC) To Rapidly Develop COVID-19-Targeting Allogeneic NK Cell Combination Therapy

Mar 31, 2020

Tsinghua University, 3rd People’s Hospital of Shenzhen and Brii Biosciences Establish Partnership to Develop Neutralizing Antibodies Against COVID-19

Mar 30, 2020

Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies Against Coronavirus That Causes COVID-19

Mar 30, 2020

GigaGen Initiates Development of Recombinant Polyclonal Antibody Therapy for COVID-19

Mar 27, 2020

Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19

Mar 26, 2020

OneThree Biotech Announces $2.5M Seed Funding and Free Toxicity Screening for Small Molecules Treating COVID-19

Mar 24, 2020

VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

Mar 24, 2020

Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine in Patients with COVID-19 Associated Respiratory Illness

Mar 24, 2020

Rafael Pharmaceuticals Enrolls More Than 75% of Patients Needed for Pivotal Phase 3 Trial (AVENGER 500) of CPI-613️ (devimistat) for Patients with Metastatic Pancreatic Cancer

Mar 24, 2020

Viriom donates Elpida to Chinese and Russian governments for experimental use against COVID-19; also working with global health authorities to determine the efficacy and safety of Elpida and its other clinical candidates AV5080, AV5124 and AV5126 against COVID-19

Mar 23, 2020

Prometheus Biosciences Launches Monitr™ COVID-19 Assistance Program (M.C.A.P.)

Mar 23, 2020

AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19

Mar 18, 2020

Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform

Mar 18, 2020

EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy Announce Initiation of an Observational Case-control Study of Siltuximab in Patients with COVID-19 who have Developed Serious Respiratory Complications

Mar 18, 2020

Golden Meditech's Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)

Mar 17, 2020

Cellenkos Inc. Focuses on the Development of Cell-Therapy for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)

Mar 12, 2020

Medicago Announces Production of a Viable Vaccine Candidate for COVID-19

Mar 11, 2020

Brii Biosciences Provides Funding to Columbia University for Research on COVID-19 and Other Coronaviruses

Mar 6, 2020

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

Mar 6, 2020

AJ Vaccines To Develop Vaccine for COVID-19

Mar 5, 2020

China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

Mar 4, 2020

EpiVax Accelerates COVID-19 Vaccine Development with UGA's Center for Vaccines and Immunology

Feb 13, 2020

Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19

Oct 23, 2018

IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL Ventures to Advance Cell Therapies for Cancer Care

Oct 23, 2018

Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for Treatment of COVID-19

Oct 23, 2018

Integral Molecular Receives NIAID Award to Combat COVID-19

Oct 23, 2018

Libbie Mansell Joins AskBio as SVP Regulatory Affairs

Oct 23, 2018

Prelude Therapeutics Announces Pricing of Initial Public Offering

Oct 23, 2018

Day One Announces Preliminary Phase 1 Results for DAY101 in Pediatric Low-Grade Glioma, Receipt of Breakthrough Therapy Designation (BTD) and New Phase 2 Study

Oct 23, 2018

BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference

Oct 23, 2018

Aruvant to Participate in the 2022 BIO CEO and Investor Gene Therapy Panel on February 16, 2022

Oct 23, 2018

Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers

Oct 23, 2018

Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell Universal Donor Adult Stem Cell Product